Chlitina Holding Limited (4137.TW)
TWD 118.0
(2.16%)
TWD 118.0
(2.16%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.96 Billion TWD | -3.13% |
| 2022 | 1.56 Billion TWD | -35.28% |
| 2021 | 2.41 Billion TWD | 37.65% |
| 2020 | 1.74 Billion TWD | -23.44% |
| 2019 | 2.29 Billion TWD | 26.29% |
| 2018 | 1.68 Billion TWD | 93.65% |
| 2017 | 904.85 Million TWD | -17.95% |
| 2016 | 1.1 Billion TWD | -26.31% |
| 2015 | 1.55 Billion TWD | 41.16% |
| 2014 | 1.1 Billion TWD | 17.35% |
| 2013 | 938.57 Million TWD | 100.77% |
| 2012 | 467.48 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 292.16 Million TWD | -42.7% |
| 2024 Q2 | 299.5 Million TWD | -11.35% |
| 2023 Q3 | 464.49 Million TWD | 26.06% |
| 2023 Q4 | 291.04 Million TWD | -37.34% |
| 2023 Q1 | 637.09 Million TWD | 61.08% |
| 2023 Q2 | 368.47 Million TWD | -42.16% |
| 2023 FY | - TWD | -3.13% |
| 2022 Q1 | 469.25 Million TWD | -24.37% |
| 2022 Q4 | 395.52 Million TWD | -23.16% |
| 2022 Q3 | 514.73 Million TWD | 173.19% |
| 2022 Q2 | 188.41 Million TWD | -59.85% |
| 2022 FY | - TWD | -35.28% |
| 2021 FY | - TWD | 37.65% |
| 2021 Q4 | 620.5 Million TWD | 0.22% |
| 2021 Q3 | 619.15 Million TWD | -0.04% |
| 2021 Q1 | 563.59 Million TWD | 4.67% |
| 2021 Q2 | 619.4 Million TWD | 9.9% |
| 2020 Q1 | 310.14 Million TWD | -50.67% |
| 2020 FY | - TWD | -23.44% |
| 2020 Q3 | 488.93 Million TWD | 15.73% |
| 2020 Q2 | 422.47 Million TWD | 36.22% |
| 2020 Q4 | 538.44 Million TWD | 10.13% |
| 2019 Q3 | 541.8 Million TWD | 4.29% |
| 2019 FY | - TWD | 26.29% |
| 2019 Q1 | 608.97 Million TWD | 30.42% |
| 2019 Q2 | 519.53 Million TWD | -14.69% |
| 2019 Q4 | 628.69 Million TWD | 16.04% |
| 2018 Q4 | 466.91 Million TWD | -2.17% |
| 2018 FY | - TWD | 93.65% |
| 2018 Q3 | 477.29 Million TWD | 12.31% |
| 2018 Q2 | 425 Million TWD | -5.8% |
| 2018 Q1 | 451.17 Million TWD | 62.44% |
| 2017 Q1 | 171.71 Million TWD | -24.14% |
| 2017 Q4 | 277.75 Million TWD | 18.26% |
| 2017 FY | - TWD | -17.95% |
| 2017 Q3 | 234.87 Million TWD | -8.14% |
| 2017 Q2 | 255.68 Million TWD | 48.9% |
| 2016 Q3 | 219.47 Million TWD | -8.37% |
| 2016 Q4 | 226.35 Million TWD | 3.14% |
| 2016 FY | - TWD | -26.31% |
| 2016 Q2 | 239.52 Million TWD | -47.97% |
| 2016 Q1 | 460.35 Million TWD | -17.04% |
| 2015 Q4 | 554.91 Million TWD | 26.53% |
| 2015 Q1 | 243.35 Million TWD | -19.67% |
| 2015 Q3 | 438.58 Million TWD | 37.98% |
| 2015 FY | - TWD | 41.16% |
| 2015 Q2 | 317.85 Million TWD | 30.62% |
| 2014 Q2 | 262.95 Million TWD | -5.24% |
| 2014 FY | - TWD | 17.35% |
| 2014 Q4 | 302.93 Million TWD | 17.42% |
| 2014 Q3 | 258 Million TWD | -1.88% |
| 2014 Q1 | 277.48 Million TWD | 18.11% |
| 2013 FY | - TWD | 100.77% |
| 2013 Q1 | 225.65 Million TWD | -2.69% |
| 2013 Q2 | 240.59 Million TWD | 6.62% |
| 2013 Q3 | 237.47 Million TWD | -1.3% |
| 2013 Q4 | 234.93 Million TWD | -1.07% |
| 2012 Q4 | 231.9 Million TWD | -0.68% |
| 2012 FY | - TWD | 0.0% |
| 2012 Q3 | 233.49 Million TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Farcent Enterprise Co.,Ltd | 355.04 Million TWD | -454.514% |
| Mao Bao Inc. | 9.01 Million TWD | -21739.101% |
| Taiyen Biotech Co., Ltd. | 518.26 Million TWD | -279.882% |
| Sanitar Co., Ltd. | 401.77 Million TWD | -390.022% |
| Jourdeness Group Limited | 802.68 Million TWD | -145.276% |
| Nan Liu Enterprise Co., Ltd. | 798.8 Million TWD | -146.468% |
| Luo Lih-Fen Holding Co., Ltd. | 120.7 Million TWD | -1531.08% |
| San Neng Group Holdings Co., Ltd. | 336.41 Million TWD | -485.23% |
| Yuen Foong Yu Consumer Products Co., Ltd. | 1.67 Billion TWD | -17.819% |
| KNH Enterprise Co., Ltd. | 1.41 Billion TWD | -39.084% |